Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Janssen Booster Evidence Draws Questions From US FDA, But Also A Nod Towards Benefits
Oct 13 2021
•
By
Derrick Gingery
The FDA's Vaccines and Related Biological Products Advisory Committee will consider whether a Janssen COVID-19 vaccine booster should be recommended. • Source: Alamy
More from Vaccines
More from Pink Sheet